Agilent Technologies Inc (A) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets.

Total Assets Chart for Agilent Technologies Inc

Agilent Technologies Inc (A) total assets for FY2025 were USD 12.7B, a 7.4% change from FY2024. Agilent Technologies Inc's total assets grew from USD 5.0B in 1998 to USD 12.7B in 2025 (155.2% over 27 years). Total assets compound annual growth rate: 5-year CAGR of 5.7%, 10-year CAGR of 5.5%, 20-year CAGR of 3.2%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$43.80B
Implied Share Price
$155.08
Enterprise Value
$45.26B
Revenue (TTM)
$7.23B
EBITDA
$2.02B
Profit Margin
19.55%
Trailing P/E
31.08
Forward P/E
23.20
Price/Book (MRQ)
6.14
Price/Sales (TTM)
6.06
EV/EBITDA
23.07
EV/Revenue
6.26
Dividend Yield
0.65%
Book Value
$25.24
Free Cash Flow (FY2025)
$1.15B
Free Cash Flow Yield
2.63%

Snapshot as of 26th August 2026 — not point-in-time controlled, may lag the live market by a few days.